Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
Atogepant for preventing migraine (new NICE guidance TA973)
Artificial intelligence (AI)-derived software to help clinical decision making in stroke (updated NICE guidance DG57)
Breakthrough advances enhancing care in ATTR amyloid cardiomyopathy 10.1016/j.ejim.2024.01.001 s
Calcium supplementation for people with overweight or obesity (new Cochrane intervention review) 10.1002/14651858.CD012268.pub2
Complication rates of central venous catheters: a systematic review and meta-analysis 10.1001/jamainternmed.2023.8232
Dementia prevention and treatment: a narrative review 10.1001/jamainternmed.2023.8522
Endometriosis: diagnosis and management (updated NICE guidance NG73)
Enduring echoes: post-infectious long-term changes in innate immunity 10.1016/j.ejim.2023.12.020
Focus on senescence: clinical significance and practical applications 10.1111/joim.13775
Gout and its management 10.1111/imj.16382
Guidance on energy and macronutrients across the life span 10.1056/NEJMra2214275
The increasing costs of medicines and their implications for patients, physicians and the health system 10.1111/imj.16370
Knowledge on cause, clinical manifestation and treatment for fibromyalgia among medical doctors: a worldwide survey 10.1111/papr.13339
Malignant ovarian and testicular germ cell tumors: common characteristics but different prognoses 10.1111/joim.13778
Reducing hospitalizations and multidrug-resistant organisms via regional decolonization in hospitals and nursing homes 10.1001/jama.2024.2759
Metabolic dysfunction-associated steatotic liver disease (MASLD): dietary and pharmacological treatment 10.1016/j.ejim.2024.01.005; management of cardiovascular risk 10.1016/j.ejim.2023.11.012; natural history 10.1016/j.ejim.2023.11.005; non-invasive testing and risk-stratification 10.1016/j.ejim.2024.01.013
Precision medicine in cardiovascular therapeutics: evaluating the role of pharmacogenetic analysis prior to drug treatment 10.1111/joim.13772
Reframing prediabetes: a call for better risk stratification and intervention 10.1111/joim.13786
Resistant hypertension: diagnosis, evaluation, and treatment practical approach 10.1016/j.ejim.2023.12.026
Systemic antibiotics for symptomatic apical periodontitis and acute apical abscess in adults (updated Cochrane intervention review) 10.1002/14651858.CD010136.pub4
Zinc for prevention and treatment of the common cold (new Cochrane intervention review) 10.1002/14651858.CD014914.pub2
Cochrane Library (Apr-May); European Journal of Internal Medicine (Apr-May); Internal Medicine Journal (Apr-May); JAMA (Apr); JAMA Internal Medicine (Apr-May); Journal of Internal Medicine (May-Jun); NEJM (10th Apr); NICE website (Apr-May); Pain Practice (Apr)
Antibiotic prophylaxis for leptospirosis (new Cochrane review) 10.1002/14651858.CD014959.pub2
Antibiotics for treatment of leptospirosis (new Cochrane review) 10.1002/14651858.CD014960.pub2
Anticoagulation in atrial fibrillation. A large real-world update 10.1016/j.ejim.2023.10.010
Association of depression with myocardial infarction with non-obstructive coronary arteries 10.55729/2000-9666.1296
Clinical presentation, course, and prognosis of patients with mixed connective tissue disease 10.1111/joim.13752
COVID-19 infection and clinical outcomes in hospitalized patients with rheumatoid arthritis: insights from the National Inpatient Sample 10.55729/2000-9666.1288
First trimester use of buprenorphine or methadone and the risk of congenital malformations 10.1001/jamainternmed.2023.6986
Lung cancer: diagnosis and management (updated NICE guideline NG122)
Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management (new NICE guideline NG240)
Neonatal infection: antibiotics for prevention and treatment (updated NICE guideline NG195)
Nonâclotting factor therapies for preventing bleeds in people with congenital hemophilia A or B (new Cochrane review) 10.1002/14651858.CD014544.pub2
Non-conventional immunomodulation in the management of sepsis 10.1016/j.ejim.2023.10.032
Nosocomial COVID-19 infection in the era of vaccination and antiviral therapy 10.1111/imj.16298
Ovarian cancer: identifying and managing familial and genetic risk (new NICE guideline NG241)
Prebiotics for induction and maintenance of remission in ulcerative colitis (new Cochrane review) 10.1002/14651858.CD015084.pub2
Prevalence and prognostic value of electrocardiographic abnormalities in hypokalemia 10.1111/joim.13757
Risk factors for malignancy and serious infection in patients with inflammatory bowel disease 10.1111/imj.16141
Smells like a variant: How the association between COVID-19 and olfactory dysfunction changed between 2019 and 2022 10.1111/joim.13760
Sodium-glucose cotransporter 2 inhibitors and nephrolithiasis risk in patients with type 2 diabetes 10.1001/jamainternmed.2023.7660
Suspected sepsis: recognition, diagnosis and early management (updated NICE guideline NG51)
Vitamin B12 deficiency in over 16s: diagnosis and management (new NICE guideline NG239)
Whipple's disease: A rare disease that can be spotted by many doctors 10.1016/j.ejim.2023.12.009
Cochrane Library (Mar); European Journal of Internal Medicine (Mar); Internal Medicine Journal (Mar); JAMA Internal Medicine (Mar); Journal of Community Hospital Internal Medicine Perspectives (Jan); Journal of Internal Medicine (Apr); NICE website (Mar)
11β-Hydroxysteroid dehydrogenase and the brain: Not (yet) lost in translation 10.1111/joim.13741
Audiovisual gamma stimulation for the treatment of neurodegeneration 10.1111/joim.13755
The current best drug treatment for hypertensive heart failure with preserved ejection fraction 10.1016/j.ejim.2023.10.008
Diagnostic errors in hospitalized adults who died or were transferred to intensive care 10.1001/jamainternmed.2023.7347
Early and locally advanced breast cancer (updated NICE guideline NG101)
Efficacy and safety of prophylactic anticoagulation in patients with primary nephrotic syndrome 10.1111/imj.16227
Evaluation of oseltamivir used to prevent hospitalization in outpatients with influenza 10.1001/jamainternmed.2023.0699
Health disinformation use case highlighting the urgent need for artificial intelligence vigilance: weapons of mass disinformation 10.1001/jamainternmed.2023.5947
Impact of antimicrobial stewardship in organisms causing nosocomial infection among COVID-19 critically ill adults 10.1016/j.ejim.2023.08.009
Intravenous iron: an update 10.1111/imj.16184
The lingering symptoms of post-COVID-19 condition (long-COVID) 10.1111/imj.16251
The Long-COVID autonomic syndrome in hospitalized patients 10.1016/j.ejim.2023.08.018
Long-term glucocorticoids in relation to the metabolic syndrome and cardiovascular disease 10.1111/joim.13739
One-year outcomes following a hypertensive urgency or emergency 10.1016/j.ejim.2023.10.020
Optoelectronic control of cardiac rhythm: Toward shock-free ambulatory cardioversion of atrial fibrillation 10.1111/joim.13744
Pathogenesis and management of immune dysfunction secondary to B cell haematological malignancies 10.1111/imj.16279
Residual cardiovascular risk: When should we treat it? 10.1016/j.ejim.2023.10.013
The role of adherence in patients with chronic diseases 10.1016/j.ejim.2023.07.008
Suspected sepsis: recognition, diagnosis and early management (updated NICE guideline NG51)
Targeting the FGF19–FGFR4 pathway for cholestatic, metabolic, and cancerous diseases 10.1111/joim.13767
Thrombo-inflammatory response in hospitalised patients with COVID-19 10.1111/imj.16285
Tracheobronchial stents: an expanding prospect 10.1111/imj.16304
Tuberculosis (updated NICE guideline NG33)
Sources used: European Journal of Internal Medicine (Jan-Feb); Internal Medicine Journal (Jan-Feb); JAMA Internal Medicine (Jan-Feb); Journal of Internal Medicine (Jan-Mar); NICE website (Jan-Feb)